TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/28/22 18:56 | 10/26/22 | PCVX | Vaxcyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fairman Jeff | CA | O | VP,Resea | S | -400 | 40.00 | 0 | -10 | -3 | 353 | I | ||||||||||||||
10/13/22 16:57 | 10/11/22 | PCVX | Vaxcyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fairman Jeff | CA | O | VP,Resea | S | -128 | 25.50 | 0 | -5 | -1 | 363 | I | ||||||||||||||
9/7/22 16:37 | 9/6/22 | PCVX | Vaxcyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fairman Jeff | CA | O | VP,Resea | S | -133 | 26.58 | 0 | -5 | -1 | 368 | M | ||||||||||||||
8/5/22 19:12 | 8/4/22 | PCVX | Vaxcyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fairman Jeff | CA | O | VP,Resea | S.m | -384 | 25.57 | 0 | -15 | -4 | 374 | I | ||||||||||||||
5/24/22 16:32 | 5/20/22 | PCVX | Vaxcyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fairman Jeff | CA | O | VP,Resea | S | -105 | 25.50 | 0 | -4 | -1 | 389 | I | ||||||||||||||
5/9/22 16:35 | 5/5/22 | PCVX | Vaxcyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fairman Jeff | CA | O | VP,Resea | S | -23 | 25.80 | 0 | -1 | 0 | 392 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |